Invivyd Reports Director Changes and Compensation Updates
Ticker: IVVD · Form: 8-K · Filed: Dec 2, 2024 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | 8-K |
| Filed Date | Dec 2, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, executive-compensation
TL;DR
Invivyd's board is shuffling, exec pay is changing. Keep an eye on this.
AI Summary
Invivyd, Inc. filed an 8-K on November 27, 2024, reporting changes in its board of directors and executive compensation arrangements. The filing indicates a departure of directors or certain officers, an election of new directors, and updates to compensatory arrangements for certain officers. Specific details regarding the individuals involved and the nature of the compensation changes were not fully elaborated in the provided text, but the report was filed on December 2, 2024.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may affect company strategy and performance.
Key Players & Entities
- Invivyd, Inc. (company) — Registrant
- Adagio Therapeutics, Inc. (company) — Former Company Name
FAQ
What specific changes were made to the board of directors?
The filing indicates an election of directors, but the specific names and details of any departures or new appointments are not provided in the excerpt.
What are the details of the compensatory arrangements for certain officers?
The filing mentions updates to compensatory arrangements for certain officers, but the specific details of these arrangements are not included in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on November 27, 2024.
What is Invivyd, Inc.'s principal executive office address?
Invivyd, Inc.'s principal executive office is located at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.
What was Invivyd, Inc.'s former company name?
Invivyd, Inc.'s former company name was Adagio Therapeutics, Inc.
Filing Stats: 403 words · 2 min read · ~1 pages · Grade level 12.6 · Accepted 2024-12-02 15:12:30
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share IVVD The Nasdaq Stock Mar
Filing Documents
- ivvd-20241127.htm (8-K) — 42KB
- 0000950170-24-132158.txt ( ) — 163KB
- ivvd-20241127.xsd (EX-101.SCH) — 31KB
- ivvd-20241127_htm.xml (XML) — 5KB
02
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (b) On November 27, 2024, Sara Cotter notified Invivyd, Inc. (the "Company") of her decision to resign from the Board of Directors of the Company and all committees thereof, effective immediately.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INVIVYD, INC. Date: December 2, 2024 By: /s/ Jill Andersen Jill Andersen Chief Legal Officer and Corporate Secretary